We are excited to announce the appointment of Chris Schade as President and CEO! Chris brings more than 20 years of public and private pharma and biotech industry experience with a strong track record of building and leading biotechnology companies. He will lead Halda as we grow and advance our new cancer fighting modality, #RIPTACtherapeutics, into clinical trials to benefit cancer patients. #HoldandKillCancer https://lnkd.in/e6EeQZGk
Halda Therapeutics
Biotechnology Research
New Haven, Connecticut 5,048 followers
Taking Hold, Conquering Cancer. Discovering novel medicines to target cancer and overcome drug resistance.
About us
Halda is inventing novel precision medicines for oncology. Specifically, we are developing RIPTAC™ therapeutics, a new drug modality for the treatment of cancer. Founded by world renowned Yale scientist, Professor Craig Crews, Halda invented RIPTAC therapeutics as an innovative cancer treatment approach that does not rely on traditional oncogenic disease drivers to target cancer. This powerful technology is designed to overcome the known bypass mechanisms of drug resistance, a common limitation of today’s precision cancer medicines. Using a novel ‘hold and kill’ mechanism, RIPTAC therapeutics target cancer cells selectively by bringing two proteins together in a tightly regulated manner, causing the loss of an essential function for cell survival and subsequent cancer cell death. We have built a pipeline of RIPTAC therapeutics for major cancer types, uniquely addressing the unmet needs of drug resistant cancer patients, and we will continue to invent new medicines using our proprietary platform technology. We are a bold company where collaboration, passion, and creativity thrive, all of which allows us to push the boundaries of drug discovery to identify better solutions. Halda is proud to be a New Haven, CT based biotech, located with headquarters and state-of-the-art labs in Science Park.
- Website
-
https://haldatherapeutics.com/
External link for Halda Therapeutics
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- New Haven, Connecticut
- Type
- Privately Held
Locations
-
Primary
115 Munson Street
Suite 101
New Haven, Connecticut 06511, US
Employees at Halda Therapeutics
Updates
-
Today we recognize #WorldCancerResearchDay and all living with cancer. We are unwavering in our mission to conquer cancer and transform the lives of cancer patients. #RIPTACtherapeutics #HoldandKillCancer #CancerResearch https://lnkd.in/d3sCkBs
-
We're proud to recognize #ProstateCancerAwarenessMonth. Bringing attention to this challenging diagnosis drives our commitment to developing RIPTAC™ therapeutics, a new class of precision medicines to conquer cancer. #TeamHalda
-
Halda is seeking an accounting manager to join the growing #TeamHalda. Please see the full job description and information on how to apply here:
-
We said farewell to summer with an ice cream break outside our office, thanks to the tenant appreciation event hosted by New Haven Science Park. Ready to welcome fall! L to R: Stephanie Scarcella, Jessica Tonini, CPA, Rebecca Stronk and Rebekka Chenard #TeamHalda
-
Thank you again ZERO Prostate Cancer for the opportunity to show up and support the patient community this past June in Hartford. See you again next year! Love this photo of Michael Martin.
September is #ProstateCancerAwarenessMonth. More than 3 million men in the U.S. are living with this disease, and 299,000 will be diagnosed this year. These numbers are unacceptable—so this month is dedicated to educating men and families about prostate cancer and how it impacts lives. Please share this post with someone you love—because raising awareness is one of the most powerful ways to get ahead of this disease. Learn more at zerocancer.org/pcam.
-
Thank you Nasdaq for recognizing our Series B financing news on the Times Square tower in NYC!
-
Halda is growing!! Help us welcome Hope Meely to Halda as our new VP of Clinical Operations. We're glad to have Hope on the team! #welcometotheteam #newhavenct #biotech #teamhalda
-
Thank you NYSE for recognizing our Series B financing news on the trading floor today in NYC!
-
Fierce Biotech offers perspective on our financing news as we move RIPTAC therapies to the clinic. #RIPTACtherapeutics #HoldandKillCancer #CancerResearch https://lnkd.in/e4WD8VP8